Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric ...
Could preserved vision be part of the growing list of health benefits associated with GLP-1 drug use? New research suggests ...
1don MSN
McDonald’s tests GLP-1 friendly menu items as Ozempic patients seek out protein-packed meals
McDonald’s signaled this week it’s looking to better cater to customers on weight-loss drugs — and the name of the game is ...
Despite their huge popularity, GLP-1 injury lawsuits citing the drugs as a cause for a host of severe GI issues and even ...
Patients wishing for an alternative to weight loss drug injections now have another option. The U.S. Food and Drug ...
GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is growing curiosity about how ...
McDonald's is exploring ways to cater to the growing number of Americans taking GLP-1 weight-loss drugs, such as Ozempic and Wegovy, by testing high-protein menu items. CEO Chris Kempczinski revealed ...
15don MSN
31 Million Americans Use GLP‑1s, but New Claims Suggest They Aren’t Being Warned About Serious Risks
Patients know about nausea and vomiting. Now, lawsuits are raising concerns about vision loss.
As the increasingly popular medications reshape the American diet, the dairy case is standing out above the rest.
Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results